aTYR PHARMA (ATYR) Non-Current Assets (2014 - 2026)
aTYR PHARMA's Non-Current Assets was $11.46 million in Q2 2026, down 18.4% from $14.04 million a year earlier and down 5.1% from the prior quarter.
Powered by 
Analysis
aTYR PHARMA (ATYR) Non-Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at aTYR PHARMA came in at $12.77 million, down 14.2% from FY2024.
- Non-Current Assets shows a five-year compound annual growth rate of 31.9% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $14.88 million in FY2024 (-15.8%), $17.66 million in FY2023 (+18.4%), $14.92 million in FY2022 (+657.9%) and $1.97 million in FY2021 (-38.4%).
- The Q2 2026 figure marks the lowest quarterly Non-Current Assets since Q3 2022.
- Compared with a year earlier, Non-Current Assets has declined for ten straight quarters, with an average decline of 13.9% over the last eight quarters.
- The best year-over-year quarter for Non-Current Assets over five years was Q1 2023 (growth of 948.3%); the worst was Q1 2022 (a decline of 44.6%).
- Per Business Quant data, ATYR's Non-Current Assets in the three quarters before Q2 2026 was $12.08 million (Q1 2026), $12.77 million (Q4 2025) and $13.64 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | aTYR PHARMA | 16.81 Mn | -276.01 Mn | - | 11.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.46 Mn |
| Mar 31, 2026 | 12.08 Mn |
| Dec 31, 2025 | 12.77 Mn |
| Sep 30, 2025 | 13.64 Mn |
| Jun 30, 2025 | 14.04 Mn |
| Mar 31, 2025 | 13.97 Mn |
| Dec 31, 2024 | 14.88 Mn |
| Sep 30, 2024 | 15.30 Mn |
| Jun 30, 2024 | 15.64 Mn |
| Mar 31, 2024 | 16.34 Mn |
| Dec 31, 2023 | 17.66 Mn |
| Sep 30, 2023 | 17.77 Mn |
| Jun 30, 2023 | 18.32 Mn |
| Mar 31, 2023 | 17.39 Mn |
| Dec 31, 2022 | 14.92 Mn |
| Sep 30, 2022 | 11.42 Mn |
| Jun 30, 2022 | 2.66 Mn |
| Mar 31, 2022 | 1.66 Mn |
| Dec 31, 2021 | 1.97 Mn |
| Sep 30, 2021 | 2.34 Mn |
API Access
aTYR PHARMA Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ATYR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ATYR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ATYR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();